Company intelligence / Profile preview

Saxovent

Ownership: Private
Development stage: Commercial

Overview

Saxovent is an independent, owner-managed investment company based in Berlin, Germany. Founded in 1997, it focuses on investments in renewable energy and climate-friendly technologies. The firm invests in innovative projects and start-ups with a focus on future-proof technologies and sustainable business models, particularly within the fields of energy and agriculture. While it has invested in industrial biotechnology companies such as Bind-X, Saxovent itself does not develop therapeutics or healthcare products[1][2][3][7].

Industry: Investors

Partnerships

Participates as an investor alongside other venture funds such as HG Ventures, K&K1, Greeneering Invest

Beyond the preview

Go deeper on Saxovent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saxovent.

Explore the full profile